Accordingly, we and other authors have shown that STn expression is responsible by the modulation of cell surface glycoprotein functions in ways that favour malignant phenotypes in gastric [26], breast [27] and bladder [5] cancers. The gene discussed is EEF1A2; the disease is cancer.